CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
Business Of Biotech
00:00
The Importance of Distributed Manufacturing in Cancer Care
The economics of CAR-T, it's pretty unfavorable for the hospital administrator set that ecosystem. Most patients with cancer want to be treated in a local environment by their local oncologists. You can't have long-term manufacturing in complicated bioreactors if you're going to move this to the community set. And that's why these technologies like next day infusions become so interesting, I think, for patients and providers.
Play episode from 29:50
Transcript
